Drreddys Laboratories | Passività Correnti



Current Liabilities Cambiamento Data
ANI Pharmaceuticals USD 201.82M 8.14M 2025-03
Aurora Cannabis CAD 149.81M 40.71M 2024-12
Bayer EUR 27.96B 993M 2025-03
Canopy Growth CAD 97.02M 184.27M 2024-12
Cipla INR 54.84B 291.6M 2025-03
Corcept Therapeutics USD 143.07M 2.29M 2025-03
Drreddys Laboratories INR 131.95B 2.65B 2024-12
GlaxoSmithKline GBP 20.83B 866M 2025-03
Hikma Pharmaceutical USD 1.38B 41M 2024-06
Lonza CHF 3.58B 970M 2024-12
Novartis USD 28.69B 560M 2024-12
Pacira USD 314.73M 4.81M 2025-03
Prestige Brands USD 106.62M 4.08M 2025-03
Richter Gedeon HUF 175.24B 34.29B 2024-12
Sun Pharmaceuticals INR 172.55B 2.71B 2024-09
Supernus Pharmaceuticals USD 292.4M 889K 2024-12
Teva Pharmaceutical Industries USD 11.16B 1.64B 2025-03



Drreddys Laboratories Passività Correnti - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - May 2025.